ACCEPT SIMS AI™

AI-enabled screening intelligence and navigation

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
3,655
Screening encounters
4,264
Diagnostic referrals
812
Outstanding pathways
293

Screening pathway

  1. Screening4,264Encounters
  2. Positive finding1,469Documented findings
  3. Referral812Diagnostic referrals
  4. Follow-up953Diagnostic visits
  5. Outcome519Resolved pathways

Stage totals use different units. Pending pathways: 293. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 4792 · EXP-4792Synthetic · Site B

Full participant history through 2026-10-13, across modalities and pathways.

  1. · Screening · VIA · Initial · Programme entry
  2. · Screening result · VIA · VIA positive · Adequate
  3. · Repeat plan · HPV DNA · Prior VIA positive · Scheduled for 2026-04-06
  4. · Diagnostic referral · EXP-4792-T-R
  5. · Contact attempt · Reached
  6. · Diagnostic booking · Initial booking
  7. · Diagnostic visit · Attended
  8. · Diagnosis · Colposcopy · Biopsy collected
  9. · Diagnosis · Histopathology · No high-grade lesion identified
  10. · Surveillance plan · HPV DNA · After clinical assessment · Scheduled for 2026-12-05
  11. · Follow-up disposition · Resolved · EXP-4792-T-R

Referral-time risk

Pathway status at observation · Resolved

Loading prediction…

Observed day-60 outcome · Resolved

Screened participants

3655 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-2134 · Expanded synthetic participant 2134Site A — Urban Referral Hub
EXP-2135 · Expanded synthetic participant 2135Site E — Resource-Constrained Navigation Programme
EXP-2136 · Expanded synthetic participant 2136Site C — Rural Outreach Programme
EXP-2137 · Expanded synthetic participant 2137Site B — Peri-Urban Access Programme
EXP-2138 · Expanded synthetic participant 2138Site D — Community Engagement Programme
EXP-2139 · Expanded synthetic participant 2139Site B — Peri-Urban Access Programme
EXP-2140 · Expanded synthetic participant 2140Site D — Community Engagement Programme
EXP-2141 · Expanded synthetic participant 2141Site A — Urban Referral Hub
EXP-2142 · Expanded synthetic participant 2142Site A — Urban Referral Hub
EXP-2143 · Expanded synthetic participant 2143Site D — Community Engagement Programme
EXP-2145 · Expanded synthetic participant 2145Site B — Peri-Urban Access Programme
EXP-2146 · Expanded synthetic participant 2146Site E — Resource-Constrained Navigation Programme
EXP-2147 · Expanded synthetic participant 2147Site D — Community Engagement Programme
EXP-2148 · Expanded synthetic participant 2148Site C — Rural Outreach Programme
EXP-2150 · Expanded synthetic participant 2150Site D — Community Engagement Programme
EXP-2151 · Expanded synthetic participant 2151Site E — Resource-Constrained Navigation Programme
EXP-2153 · Expanded synthetic participant 2153Site C — Rural Outreach Programme
EXP-2154 · Expanded synthetic participant 2154Site A — Urban Referral Hub
EXP-2155 · Expanded synthetic participant 2155Site B — Peri-Urban Access Programme
EXP-2157 · Expanded synthetic participant 2157Site A — Urban Referral Hub
EXP-2159 · Expanded synthetic participant 2159Site C — Rural Outreach Programme
EXP-2160 · Expanded synthetic participant 2160Site A — Urban Referral Hub
EXP-2161 · Expanded synthetic participant 2161Site A — Urban Referral Hub
EXP-2162 · Expanded synthetic participant 2162Site C — Rural Outreach Programme
EXP-2163 · Expanded synthetic participant 2163Site A — Urban Referral Hub

Programme insights

Encounters by modality

VIA
1659
HPV DNA
2006
Cytology
599

Navigation activity

Barrier documented
716
Contact attempt
1189
Navigation intervention
306
Diagnostic booking
1008
Diagnostic visit
953

Documented barriers

Contact difficulty
230
Transport difficulty
233
Appointment coordination
253

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.